Dr. Genessis Maldonado

Dr. Genessis Maldonado |Clyto Access

Universidad de Especialidades Espíritu Santo (UEES), Ecuador

Organizing Committee Member
Speaker

Expertise: Rheumatology, Evidence Based Medicine, Diabetes

Biography:

Dr. Genessis Maldonado is an Ecuadorian general medical physician, that graduated in 2016 from Universidad de Especialidades Espiritu Santo in Guayaquil, Ecuador. In 2013 – 2016 she participated as a physician teaching assistant for cellular biology, immunology and rheumatology. Her interest in research began in 2014 while helping Dr. Carlos Rios, Director of CERER (Centro de Reumatologia y Rehabilitacion) and president of the Ecuadorian Rheumatology Society in the first epidemiological study for rheumatoid arthritis in Ecuador, which has been presented in the 47th, 48th and 49th Argentinian Congress of Rheumatology for follow up and is currently awaiting approval for publication in the Open Access Rheumatology journal. With Dr. Rios as a mentor, she has given 13 international and Ecuadorian oral presentations in rheumatology related medical congresses, published 10 studies in international indexed journals, 30 abstracts for poster presentations in both Ecuadorian and international rheumatology congresses including the Annual Meeting of the American College of Rheumatology in 2015 & 2016 and World Congress of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases. Along with Dr. Rios, they are pioneers in the use of nail-fold capillaroscopy in the rheumatological field in Ecuador, and authors of the first edition of Nailfold Capillaroscopy handbook, endorsed by the Panamerican League of Associations for Rheumatology.

Presentation:

Title: Nailfold capillaroscopy in Diabetes Mellitus

Abstract:

Diabetes is characterized by a chronic hyperglycemic state and the development of alterations in the vascular structure. It’s currently considered a chronic disease with a high mortality rate due to its longterm cardiovascular and renal complications(1,2).Data from the Diabetes Control and Complications Trial (DCCT) and the UK Prospective Diabetes Study (UKPDS) shows that chronic hyperglycemia is the most important risk factor for the development of microvascular complications in patients with type I and II diabetes mellitus(3,4) and that endothelial dysfunction plays an important role in the development of vascular diseases and represents the initial stage in pathogenesis of the disease(6). The current trend for evaluating microvascular damage in diabetic patients is the use of: Doppler flowmetry, direct and indirect ophthalmoscopy, ambulatory blood pressure monitoring(7), but capillaroscopy is not commonly used.Because of diabetes important vascular involvement, direct observation tools such as ophthalmoscopes, and magnifying lenses have been used during examination. In recent years, capillaroscopy has gained recognition in the field of diseases that affect capillary microarchitecture, especially in rheumatic diseases(5); however, studies published in the last decade highlight the importance of this innovative technique in non- rheumatic diseases such as diabetes(6–9). These studies conclude that capillaroscopy provides important data for the determination of vascular damage in diabetic patients, allowing an evaluation in the progression of the disease(10).

Related Conferences :

International Diabetes and Degenerative Diseases Conference